Aleen Lee, MD
Otolaryngology · Clackamas, ORNPI 1134447741
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,907 of the $2,990 with a category attached, or 63.8%. Aerin Medical Inc. accounts for 64.1% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $1,651, 3.8 times the $433 reported in 2019.
Across 42 payments — averaging $71.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Intersect ENT, Inc.$390
- Medtronic$366
- Jazz Pharmaceuticals Inc.$96
- Optinose US, Inc.$54
- KARL Storz Endoscopy-america$49
- plus $117 from 5 others
What the payments were for
- Travel & lodging$1,08436%
- Food & beverage$1,90764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 15 | $1,918 |
| Intersect ENT, Inc. | 6 | $390 |
| Medtronic(2 entities) | 7 | $366 |
| Jazz Pharmaceuticals Inc. | 3 | $96 |
| Optinose US, Inc. | 3 | $54 |
| KARL Storz Endoscopy-america | 1 | $49 |
| Sanofi | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Stryker | 2 | $24 |
| Arrinex, Inc. | 1 | $16 |
| Acclarent, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,268
- PROPEL$254
- RHINAER STYLUS$133
How this compares
$2,990 in reported general payments places this provider in the 85th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 81 | $2,492 |
| Azelastine Hcl | 30 | $730 |
| Ciprofloxacin Hcl | 26 | $449 |
| Prednisone | 32 | $370 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $153 |
| Nortriptyline Hcl | 27 | $138 |
| Omeprazole | 11 | $95 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Clackamas
- Caroline YangClackamas$3K
- John Richards IiClackamas$2K
- John GoddardClackamas$639
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Andrew BakerMilwaukie$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.